Ardelyx Inc

ARDX

Company Profile

  • Business description

    Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

  • Contact

    400 Fifth Avenue
    Suite 210
    WalthamMA02451
    USA

    T: +1 510 745-1700

    E: [email protected]

    https://www.ardelyx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    267

Stocks News & Analysis

stocks

Are investors missing the boat on this future ASX leader?

The market is underestimating the clear path to profitability.
stocks

ASX shares plunge but remain undervalued

Shares drop 17% after guidance is revised but we still see value.
stocks

Ask the analyst: Why have markets shunned APA Group?

Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,456.8015.00-0.18%
CAC 407,429.485.810.08%
DAX 4020,319.6448.310.24%
Dow JONES (US)42,518.28221.160.52%
FTSE 1008,262.9561.410.75%
HKSE19,286.0766.290.34%
NASDAQ19,044.3943.71-0.23%
Nikkei 22538,444.5829.72-0.08%
NZX 50 Index12,943.5759.190.46%
S&P 5005,842.916.690.11%
S&P/ASX 2008,213.3017.70-0.22%
SSE Composite Index3,227.1213.82-0.43%

Market Movers